Sitavig

50 MG — MUCO-ADHESIVE BUCCAL TABLET

Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Coverage by Insurer

Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
Source: Excel (XLSX)  ·  Formulary date: Sep 23, 2026  ·  Checked: 5 hours, 29 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
TRICARE Uniform Formulary 2026 Tier 2 - Brand Formulary ✓ — ✓ BUCCAL SITAVIG TO BE DISPENSED AT A MAXIMUM QUANTITY OF 2 TABLETS IN 21 DAYS PA | QL PA: 1270/48001/90693 PA DRUGS, DOD PA REQUIRED; Quantity limit
Something not right?